Tyme Technologies, Inc.

Home » Tyme Technologies, Inc.

Secondary

Tyme Technologies, Inc.

Tyme Technologies, Inc. is a clinical-stage biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types while having a low toxicity profile.

Symbol

TYME

Last Closing Price
$3.88

Shares
12,000,000

Effective Date
March 1, 2018

Underwriters
Evercore, Stifel, Canaccord

To view the prospectus for Tyme Technologies, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253